Search

Your search keyword '"Sara, S."' showing total 1,628 results

Search Constraints

Start Over You searched for: Author "Sara, S." Remove constraint Author: "Sara, S." Topic neoplasms Remove constraint Topic: neoplasms
1,628 results on '"Sara, S."'

Search Results

1. The use of platelets as a clinical tool in oncology: opportunities and challenges.

2. Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis Cancers.

3. The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors.

4. Albumin-based strategies to effectively prolong the circulation half-life of small immunomodulatory payloads in cancer therapy.

5. Targeting CDK2 to combat drug resistance in cancer therapy.

6. Alkaloids in Cancer therapy: Targeting the tumor microenvironment and metastasis signaling pathways.

7. Effectiveness of tailored talks between a cancer screening specialist and general practitioners to improve the uptake of colorectal cancer screening in Ancona (Italy) during the pandemic period.

8. Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal products.

9. Implementation and evaluation of a navigation program for people with cancer in old age and their family caregivers: study protocol for the EU NAVIGATE International Pragmatic Randomized Controlled Trial.

10. Prevalence and molecular identification of protozoan intestinal parasitic infections in cancer patients and a control group.

11. Generative adversarial networks accurately reconstruct pan-cancer histology from pathologic, genomic, and radiographic latent features.

12. Preliminary guidelines for the detection and management of drug-related problems in cancer patients with type 2 diabetes mellitus: a practical resource for oncology pharmacists.

13. Significant Advancements and Evolutions in Chimeric Antigen Receptor Design.

14. Second Opinion Seeking in Paediatric Oncology: Motivations and Predictors.

15. Physiological and tumor-associated angiogenesis: Key factors and therapy targeting VEGF/VEGFR pathway.

16. Validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries: a retrospective, comparative analysis.

17. Availability and financing of CAR-T cell therapies: A cross-country comparative analysis.

18. Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants.

19. A narrative review: exploring viral-induced malignancies through the lens of dysregulated cellular metabolism and glucose transporters.

20. Photodynamic Therapy: Past, Current, and Future.

21. Worse Psychological Profiles Are Associated With Higher Levels of Stress and Symptom Burden in Patients With Cancer During the COVID-19 Pandemic.

22. Nonadditive Effects of Common Genetic Variants Have a Negligent Contribution to Cancer Heritability.

23. The Role of Microbiome and Probiotics in Chemo-Radiotherapy-Induced Diarrhea: A Narrative Review of the Current Evidence.

24. Perceived benefits and challenges of using an electronic cancer prediction system for safety netting in primary care: An exploratory study of C the signs.

25. Evaluation of a novel blood collection set for venipuncture in oncology patients with difficult venous access: Impact on sample quality, phlebotomist satisfaction and patient pain perception.

27. Comprehensive fertility preservation can be offered in a timely manner around gonadotoxic therapy in children and adolescents.

28. Is oral nano-curcumin formulation a safe and effective measure for preventing cisplatin-induced nephrotoxicity in cancer patients?

29. Predicting Antigen-Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDist.

30. A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors.

31. Modulation of the ubiquitin-proteasome system by curcumin: Therapeutic implications in cancer.

32. The implications of the TNFα-TNFR2 immune checkpoint signaling pathway in cancer treatment: From immunoregulation to angiogenesis.

33. DNA methylation in mammalian development and disease.

34. PeptiHub: a curated repository of precisely annotated cancer-related peptides with advanced utilities for peptide exploration and discovery.

35. Immune-Mediated Inflammatory Diseases and Cancer - a dangerous liaison.

36. Association of housing status and cancer diagnosis, care coordination and outcomes in a public hospital: a retrospective cohort study.

37. Glycosylation in cancer as a source of biomarkers.

38. Reciprocal Interactions Between Apelin and Noncoding RNAs in Cancer Progression.

39. Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial.

40. Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success.

41. Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg-Depleting Antibody.

42. Novel insight into mitochondrial dynamin-related protein-1 as a new chemo-sensitizing target in resistant cancer cells.

43. Micronuclear collapse from oxidative damage.

44. The impact of the COVID-19 pandemic on health-related quality of life of cancer patients in British Columbia.

45. Propolis: a natural compound with potential as an adjuvant in cancer therapy - a review of signaling pathways.

46. Assessment of barriers to cancer screening and interventions implemented to overcome these barriers in 27 Latin American and Caribbean countries.

47. Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials.

48. Opportunities for Improving Detection of Cancer Predisposition Syndromes in Pediatric Solid Tumor Patients.

49. Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study.

50. Delta radiomics: an updated systematic review.

Catalog

Books, media, physical & digital resources